Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Germain Bessard

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
La Revue Du Praticien|February 14, 2009
[Diuretic therapy]Germain Bessard, Sandrine Bacquaert, Audrey Revol
Therapie|November 7, 2007
[Immunosuppressive drugs and highly active antiretroviral therapy: pharmacokinetic interactions]Johnny Moretto, Germain Bessard, Françoise Stanke-Labesque
Trends in Pharmacological Sciences|October 16, 2002
Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implicationsJean-Luc Cracowski, Thierry Durand, Germain Bessard
Journal of the American College of Cardiology|February 2, 2002
Vasomotor effects and pathophysiologic relevance of F(2)-isoprostane formation in vascular diseasesJean Luc Cracowski, Stephanie Marliere, Germain Bessard
The American Journal of Gastroenterology|April 16, 2009
Comment on a retractionBruno Bonaz, Germain Bessard, Jean-Pierre Zarski
Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2002
Physiological variations of isoprostanes: a step forward?Jean-Luc Cracowski, Françoise Stanke-Labesque, Germain Bessard
Journal of Hypertension|December 7, 2005
Effect of 5-lipoxygenase blockade on blood pressure and acetylcholine-evoked endothelium-dependent contraction in aorta from spontaneously hypertensive ratsBlandine Lefebvre, Françoise Caron, Germain Bessard, et al.
Therapie|June 18, 2004
[Genetic polymorphism and treatment of chronic bowel inflammatory diseases: the example of azathioprine]Germain Bessard, Gaëlle Hardy, Alain Chartier, et al.
British Journal of Pharmacology|September 12, 2003
Inhibition of leukotriene synthesis with MK-886 prevents a rise in blood pressure and reduces noradrenaline-evoked contraction in L-NAME-treated ratsFrançoise Stanke-Labesque, Gaëlle Hardy, Françoise Caron, et al.
Inflammatory Bowel Diseases|February 21, 2008
Urinary leukotriene E4 excretion: a biomarker of inflammatory bowel disease activityFrançoise Stanke-Labesque, Joanna Pofelski, Alexandre Moreau-Gaudry, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
La Revue Du Praticien|February 14, 2009
[Diuretic therapy]Germain Bessard, Sandrine Bacquaert, Audrey Revol
Therapie|November 7, 2007
[Immunosuppressive drugs and highly active antiretroviral therapy: pharmacokinetic interactions]Johnny Moretto, Germain Bessard, Françoise Stanke-Labesque
Trends in Pharmacological Sciences|October 16, 2002
Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implicationsJean-Luc Cracowski, Thierry Durand, Germain Bessard
Journal of the American College of Cardiology|February 2, 2002
Vasomotor effects and pathophysiologic relevance of F(2)-isoprostane formation in vascular diseasesJean Luc Cracowski, Stephanie Marliere, Germain Bessard
The American Journal of Gastroenterology|April 16, 2009
Comment on a retractionBruno Bonaz, Germain Bessard, Jean-Pierre Zarski
Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2002
Physiological variations of isoprostanes: a step forward?Jean-Luc Cracowski, Françoise Stanke-Labesque, Germain Bessard
Journal of Hypertension|December 7, 2005
Effect of 5-lipoxygenase blockade on blood pressure and acetylcholine-evoked endothelium-dependent contraction in aorta from spontaneously hypertensive ratsBlandine Lefebvre, Françoise Caron, Germain Bessard, et al.
Therapie|June 18, 2004
[Genetic polymorphism and treatment of chronic bowel inflammatory diseases: the example of azathioprine]Germain Bessard, Gaëlle Hardy, Alain Chartier, et al.
British Journal of Pharmacology|September 12, 2003
Inhibition of leukotriene synthesis with MK-886 prevents a rise in blood pressure and reduces noradrenaline-evoked contraction in L-NAME-treated ratsFrançoise Stanke-Labesque, Gaëlle Hardy, Françoise Caron, et al.
Inflammatory Bowel Diseases|February 21, 2008
Urinary leukotriene E4 excretion: a biomarker of inflammatory bowel disease activityFrançoise Stanke-Labesque, Joanna Pofelski, Alexandre Moreau-Gaudry, et al.
Pageof 3